Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
23 results
D1.306 - Cold-induced urticaria: Phenotypic characterization and risk factors for cold-induced anaphylaxis
D1.307 - Lipid metabolic remodeling in Food-induced anaphylaxis revealed by integrated proteomic and lipidomic analyses
D1.313 - Clinical Characteristics of Chronic Urticaria Patients With and Without Flares With Systemic Symptoms
D1.315 - IgE antibody function and mast cell activation to egg in children undergoing baked and loosely cooked egg challenges
D1.319 - Efficacy of Omalizumab in Refractory Cholinergic Urticaria and Cholinergic Anaphylaxis: A Case Series
D1.304 - Exercise-induced anaphylaxis misdiagnosed as cholinergic urticaria in a child: a case report
D1.308 - Severe Chronic Spontaneous Urticaria with Recurrent Anaphylaxis and Extreme IgE Elevation Associated with Innate Immune Dysregulation
D1.309 - The complexity of basal serum tryptase levels: Genotyping tryptase genes is not enough
D1.314 - Endothelial glycocalyx shedding in IgE- and IgG-mediated anaphylaxis
D1.316 - Identification of lipid classes to differentiate anaphylactic from non-anaphylactic allergic reactions. BANA study
D1.317 - Systemic inflammatory indices in relation to anaphylaxis symptoms in adults with food allergy
D1.320 - IgE-mediated Perioperative Anaphylaxis to Latex with Concomitant Local Anesthetic Hypersensitivity in a Mexican Teenager: a Policy-Changing Case Report
- D1.532 - Phenotypic and Functional Comparison of LAD2, HMC-1.2, and Primary Human Mast Cells
- D1.529 - Evaluating the Disease-Modifying Potential of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis: An Update on the Pivotal HARBOR Study
- D1.530 - Patient Experience of Most Burdensome Nonadvanced Systemic Mastocytosis Symptoms From the Pivotal Summit Trial of Bezuclastinib
- D1.531 - Avapritinib in Indolent Systemic Mastocytosis: Real-world Data from a Greek Case Series
- D1.533 - Systemic mastocytosis despite normal baseline tryptase: a diagnostic pitfall in recurrent life-threatening anaphylaxis
D3.455 - Comparative Characterization of Olfactory Dysfunction in Mouse Models of Eosinophilic Chronic Rhinosinusitis
D3.456 - BEAMER: A multidisciplinary model for disease-agnostic adherence integrating chronic rhinosinusitis: development and prospective study
D3.451 - Long-term follow-up of ASA therapy after desensitization in patients with chronic rhinosinusitis with nasal polyps indicates high rate of treatment discontinuation
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download